RVTY
US EQUITY
Health Care
Health Care Equipment
CIK: 31791
Revvity (RVTY) Quant Factor Diagnostic & Fair Value Model
Revvity (Ticker: RVTY) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$158.77
+0.90%
Latest Close (2026-10-23)
Market Cap: $16.84B
P/E Ratio: 84.5
Momentum Strength
3M / 12M
+46.91%
1M: +5.37%
12M: +65.94%
Quality (ROE)
Point-in-Time
+2.87%
Trailing Return on Equity
Technical Trend
RSI 14
52.6
SMA50: $140.08
SMA200: $110.49
Valuation Multiplier
Trailing
84.5
Premium Multiple (> 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)
RVTY trades at 84.5x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 7/9 (High Financial Strength)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 31791 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-07-05 | 2026-08-11 | - | $51.82M | $307.17M | $0.47 |
| 10-Q | 2026-04-05 | 2026-08-11 | - | $40.72M | $115.23M | $0.36 |
| 10-Q | 2025-12-28 | 2026-08-11 | - | - | - | - |
| 10-Q | 2025-06-29 | 2026-08-11 | - | $53.95M | $262.47M | $0.46 |
| 10-Q | 2025-03-30 | 2026-08-11 | - | $42.24M | $128.16M | $0.35 |
| 10-K | 2025-12-28 | 2026-02-24 | - | $241.20M | $582.93M | $2.07 |
| 10-K | 2024-12-29 | 2026-02-24 | - | $270.38M | $628.30M | $2.20 |
| 10-K | 2023-12-31 | 2026-02-24 | - | $693.09M | $91.27M | $5.55 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Revvity (RVTY) valuation multiples, momentum factors, and point-in-time filing conventions.
How should RVTY's current valuation multiple be interpreted? ↓
RVTY trades at a trailing P/E of 84.5x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are RVTY's key momentum and technical factor indicators? ↓
As of the latest close, RVTY shows a 1-month return of +5.37%, 3-month return of +46.91%, and 12-month return of +65.94%, with a 14-day RSI of 52.6. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for RVTY? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can RVTY be incorporated into systematic factor models? ↓
RVTY can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.